Clinical Trials Directory

Trials / Completed

CompletedNCT05897463

Nipple Neurotization

Breast and Nipple Neurotization Via Elongation of the Lateral Cutaneous Branches Using Intercostal Branches

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

A retrospective chart review will be conducted to identify patients receiving breast reconstruction and simultaneous breast neurotization. Their reconstructed breasts will be included as study group. Patients receiving breast reconstruction without neurotization will be included as negative control group. Their contralateral normal breasts in the study and the negative control group will be included as positive control. Patients' demographic data, their breast cancer treatment parameters, such as the staging, previous radiotherapy history, postmastectomy radiotherapy, neoadjuvant and adjuvant chemotherapy will be included. The reconstruction results will be evaluated as well. Statistics Data will be analyzed using graphing and statistical analysis software. Independent t test will be applied to calculate continuous variables in demographic values, while Chi-square will be applied to calculate categorical variables such as postoperative complications. A probability of less than 0.05 will be considered significant. Potential risks: No Confidentiality: All the patient identifiable information, which includes name, chart number and birthday, involved in the study will be strictly confidential.

Conditions

Timeline

Start date
2022-09-01
Primary completion
2023-03-31
Completion
2023-03-31
First posted
2023-06-09
Last updated
2023-06-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05897463. Inclusion in this directory is not an endorsement.